The increase of IL-6 in the DSS-treated group and, at a lesser extent after AOM, and altogether the persistence of IL-1α and IFN-γ at still valid levels in relation to TGF-β1, can cooperate to maintain the activity of the inflammation. The gene discussed is IL6; the disease is infectious otitis media.